Thursday, 3 January 2019

FDA Approves Commercial Production for Bleeding Antidote Andexxa - Medscape

FDA Approves Commercial Production for Bleeding Antidote Andexxa  Medscape

The US Food and Drug Administration (FDA) has approved a prior approval application that should allow for "broad commercial launch in the United States" of ...

No comments:

Post a Comment